Sildenafil Tablet, Film Coated
Product Images NDC 68071-5115

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 68071-5115). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 5115 6)

NuCare Pharmaceuticals, Inc. has produced a pack of Sildenafil 20mg tablets with Lot number 000000 and NDC: 68071-5115-06, having a total of 662 tablets. The MFR NDC code is 33342-121-10 with an expiry date of 00-00 and serial# 00000000002. The box contains white tablets with imprinted characters BIpU] ‘Yseprid [eysewl 19826 ¥0 ‘ebusio :Aq paamorjnuep ‘3u] ‘S[BINNBIBULIBYJ JBDINN. It is recommended to keep out of reach of children and store at a controlled temperature of 59-86°F. For side effects, medical advice may be sought, or FDA may be reported at 1-800-FDA-1088.*

FDA Label Image

Figure-10 (Sildenafil Fig 10)

FDA Label Image

Figure-11 (Sildenafil Fig 11)

FDA Label Image

Fig-12 (Sildenafil Fig 12)

FDA Label Image

Fig-6 (Sildenafil Fig 6)

FDA Label Image

Fig-8 (Sildenafil Fig 8)

The text contains a table showing the recommendations on dosage adjustment for several drugs when interacting with other drugs. The table shows whether a dose adjustment is needed or not when taking a specific drug together with another drug. There is also a graph showing the change in fold relative to the interacting drug alone. The text may contain some errors, but the general idea of the table and graph is understandable.*

FDA Label Image

Figure-9 (Sildenafil Fig 9)

FDA Label Image

Figure-7 (Sildenafil Figure 7)

This is a drug interaction chart that provides recommendations for dose adjustments based on fold change and %0% CI. It involves drugs such as Atorasttn, Astromycn UG, Bosentan, Cimetidine, Evermyel:f, beoanod c, Oral Contraceptives and Saquinavie. The chart also shows a comparison of relative change with Sildenafil alone through a solid line at x=1, and highlights that there is no added benefit on exercise capacity when sildenafil is added to bosentan therapy based on clinical studies.*

FDA Label Image

Str (Sildenafil Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.